Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Sep-21 8:00 PM View:  | Corcoran E Thomas Director | Phibro Animal Health Corp (PAHC) | 30-Aug-21 | Market Purchase | 5,000 | $23.68 | $118,400.00 | 33% 15.0K to 20.0K | (< 1%) |
| 10-Feb-21 8:01 PM View: | Miller Larry Lars Chief Operating Officer | Phibro Animal Health Corp (PAHC) | 09-Feb-21 | Market Option Sale | 20,000 | $22.94 | $458,812.00 | (40%) 50.0K to 30.0K | (2%) |
| 10-Feb-21 8:01 PM View: | Miller Larry Lars Chief Operating Officer | Phibro Animal Health Corp (PAHC) | 08-Feb-21 | Option Exercise | 50,000 | -- | -- | 100% 0 to 50.0K | |
| 04-Sep-19 9:53 PM View: | Corcoran E Thomas Director | Phibro Animal Health Corp (PAHC) | 30-Aug-19 | Market Purchase | 5,000 | $21.21 | $106,050.00 | 50% 10.0K to 15.0K | 7% |
| 30-Jan-19 9:07 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 30-Jan-19 | Market Option Sale (Planned) | 2,390 | $31.15 | $74,448.50 | (100%) 2.39K to 0 | 28% |
| 30-Jan-19 9:07 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 30-Jan-19 | Option Exercise | 2,390 | $11.83 | $28,273.70 | 100% 0 to 2.39K | |
| 30-Jan-19 9:07 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 29-Jan-19 | Market Option Sale (Planned) | 4,890 | $31.32 | $153,155.00 | (100%) 4.89K to 0 | 28% |
| 30-Jan-19 9:07 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 29-Jan-19 | Option Exercise | 4,890 | $11.83 | $57,848.70 | 100% 0 to 4.89K | |
| 30-Jan-19 9:07 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 28-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 30-Jan-19 9:07 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 28-Jan-19 | Market Option Sale (Planned) | 2,500 | $31.55 | $78,875.00 | (100%) 2.5K to 0 | 29% |
| 24-Jan-19 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 24-Jan-19 | Market Option Sale (Planned) | 2,500 | $31.78 | $79,450.00 | (100%) 2.5K to 0 | 29% |
| 24-Jan-19 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 24-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 24-Jan-19 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 23-Jan-19 | Market Option Sale (Planned) | 2,500 | $31.72 | $79,304.00 | (100%) 2.5K to 0 | 29% |
| 24-Jan-19 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 23-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 24-Jan-19 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 22-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 24-Jan-19 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 22-Jan-19 | Market Option Sale (Planned) | 2,500 | $31.40 | $78,500.00 | (100%) 2.5K to 0 | 28% |
| 18-Jan-19 9:00 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 18-Jan-19 | Market Option Sale (Planned) | 2,500 | $32.04 | $80,100.00 | (100%) 2.5K to 0 | 30% |
| 18-Jan-19 9:00 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 18-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 18-Jan-19 9:00 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 17-Jan-19 | Market Option Sale (Planned) | 2,500 | $32.24 | $80,600.00 | (100%) 2.5K to 0 | 30% |
| 18-Jan-19 9:00 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 17-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 18-Jan-19 9:00 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 16-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 18-Jan-19 9:00 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 16-Jan-19 | Market Option Sale (Planned) | 2,500 | $32.40 | $81,000.00 | (100%) 2.5K to 0 | 30% |
| 17-Jan-19 9:13 PM View: | Warras Dean J Pres Animal Health & Nutr N.A. | Phibro Animal Health Corp (PAHC) | 15-Jan-19 | Option Exercise | 21,560 | $11.83 | $255,055.00 | 100% 0 to 21.56K | |
| 17-Jan-19 9:13 PM View: | Warras Dean J Pres Animal Health & Nutr N.A. | Phibro Animal Health Corp (PAHC) | 15-Jan-19 | Market Option Sale (Planned) | 21,560 | $31.81 | $685,824.00 | (100%) 21.56K to 0 | 29% |
| 10-Jan-19 9:14 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 09-Jan-19 | Market Option Sale (Planned) | 2,500 | $32.54 | $81,350.00 | (100%) 2.5K to 0 | 31% |
| 10-Jan-19 9:14 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 09-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 10-Jan-19 9:14 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 08-Jan-19 | Market Option Sale (Planned) | 2,500 | $32.31 | $80,775.00 | (100%) 2.5K to 0 | 30% |
| 10-Jan-19 9:14 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 08-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 07-Jan-19 8:08 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 07-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 07-Jan-19 8:08 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 07-Jan-19 | Market Option Sale (Planned) | 2,500 | $32.21 | $80,525.00 | (100%) 2.5K to 0 | 30% |
| 07-Jan-19 8:08 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 04-Jan-19 | Market Option Sale (Planned) | 2,500 | $31.30 | $78,250.00 | (100%) 2.5K to 0 | 28% |
| 07-Jan-19 8:08 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 04-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 07-Jan-19 8:08 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 03-Jan-19 | Market Option Sale (Planned) | 2,500 | $31.72 | $79,300.00 | (100%) 2.5K to 0 | 29% |
| 07-Jan-19 8:08 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 03-Jan-19 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 05-Nov-18 9:07 PM View: | Warras Dean J Pres Animal Health & Nutr N.A. | Phibro Animal Health Corp (PAHC) | 01-Nov-18 | Option Exercise | 10,000 | $11.83 | $118,300.00 | 100% 0 to 10.0K | |
| 05-Nov-18 9:07 PM View: | Warras Dean J Pres Animal Health & Nutr N.A. | Phibro Animal Health Corp (PAHC) | 01-Nov-18 | Market Option Sale (Planned) | 10,000 | $42.84 | $428,414.00 | (100%) 10.0K to 0 | 48% |
| 14-Sep-18 9:03 PM View: | Bendheim Jack President and CEO Director 10% Owner | Phibro Animal Health Corp (PAHC) | 12-Sep-18 | Market Sale (Planned) Duplicate | 520 | $45.04 | $23,420.80 | (< 1%) 60.0K to 59.48K | 50% |
| 14-Sep-18 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 12-Sep-18 | Option Exercise | 2,500 | $11.83 | $29,575.00 | 100% 0 to 2.5K | |
| 14-Sep-18 9:03 PM View: | Bendheim Jack President and CEO Director 10% Owner | Phibro Animal Health Corp (PAHC) | 12-Sep-18 | Conversion Duplicate | 30,000 | -- | -- | 100% 30.0K to 60.0K | |
| 14-Sep-18 9:04 PM View: | Bfi Co., LLC 10% Owner | Phibro Animal Health Corp (PAHC) | 12-Sep-18 | Conversion | 30,000 | -- | -- | 100% 30.0K to 60.0K | |
| 14-Sep-18 9:04 PM View: | Bfi Co., LLC 10% Owner | Phibro Animal Health Corp (PAHC) | 12-Sep-18 | Market Sale (Planned) | 520 | $45.04 | $23,420.80 | (< 1%) 60.0K to 59.48K | 50% |
| 14-Sep-18 9:04 PM View: | Bendheim Daniel M Exec. VP, Corporate Strategy Director | Phibro Animal Health Corp (PAHC) | 12-Sep-18 | Market Option Sale (Planned) | 2,500 | $44.30 | $110,750.00 | (100%) 2.5K to 0 | 49% |
| 06-Sep-18 9:24 PM View: | Bfi Co., LLC 10% Owner | Phibro Animal Health Corp (PAHC) | 06-Sep-18 | Market Sale (Planned) | 10,000 | $46.97 | $469,718.00 | (25%) 40.0K to 30.0K | 52% |
| 06-Sep-18 9:26 PM View: | Bendheim Jack President and CEO Director 10% Owner | Phibro Animal Health Corp (PAHC) | 06-Sep-18 | Market Sale (Planned) Duplicate | 10,000 | $46.97 | $469,718.00 | (25%) 40.0K to 30.0K | 52% |
| 06-Sep-18 9:26 PM View: | Bendheim Jack President and CEO Director 10% Owner | Phibro Animal Health Corp (PAHC) | 05-Sep-18 | Conversion Duplicate | 20,000 | -- | -- | 67% 30.0K to 50.0K | |
| 06-Sep-18 9:24 PM View: | Bfi Co., LLC 10% Owner | Phibro Animal Health Corp (PAHC) | 05-Sep-18 | Conversion | 20,000 | -- | -- | 67% 30.0K to 50.0K | |
| 06-Sep-18 9:26 PM View: | Bendheim Jack President and CEO Director 10% Owner | Phibro Animal Health Corp (PAHC) | 05-Sep-18 | Market Sale (Planned) Duplicate | 10,000 | $47.30 | $473,000.00 | (20%) 50.0K to 40.0K | 52% |
| 06-Sep-18 9:24 PM View: | Bfi Co., LLC 10% Owner | Phibro Animal Health Corp (PAHC) | 05-Sep-18 | Market Sale (Planned) | 10,000 | $47.30 | $473,000.00 | (20%) 50.0K to 40.0K | 52% |
| 23-Aug-18 9:18 PM View: | Bendheim Jack President and CEO Director 10% Owner | Phibro Animal Health Corp (PAHC) | 23-Aug-18 | Market Sale (Planned) Duplicate | 10,000 | $49.84 | $498,400.00 | (25%) 40.0K to 30.0K | 55% |
| 23-Aug-18 9:18 PM View: | Bfi Co., LLC 10% Owner | Phibro Animal Health Corp (PAHC) | 23-Aug-18 | Market Sale (Planned) | 10,000 | $49.84 | $498,400.00 | (25%) 40.0K to 30.0K | 55% |
